CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells

Li Wang1, Wei Chen2, Zheng Zhang1, Yong‐Qiang Deng3, Jianqi Lian4, Peng Du2, Wei Ding1, Zhang Yang1, Xiuxuan Sun1, Li Gong4, Yang Xu1, Lei He3, Lei Zhang5, Zhiwei Yang5, Jiejie Geng1, Ruo Chen1, Zhang Hai1, Bin Wang1, Yumeng Zhu1, Gang Nan1, Jian‐Li Jiang1, Ling Li1, Jiao Wu1, Lin Peng1, Wan Huang1, Liangzhi Xie6, Zhaohui Zheng7, Kui Zhang7, Jinlin Miao1, Hong‐Yong Cui1, Min Huang1, Jun Zhang2, Ling Fu2, Xiang-Min Yang1, Zhongpeng Zhao3, Shihui Sun3, Hongjing Gu3, Zhe Wang8, Chunfu Wang4, Ya-Cheng Lu8, Yingying Liu8, Qingyi Wang8, Huijie Bian1, Ping Zhu7, Zhi‐Nan Chen1
1National Translational Science Center for Molecular Medicine & Department of Cell Biology, Fourth Military Medical University, Xi'an 710032, China
2Beijing Institute of Biotechnology, Beijing 100071, China
3State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing 100071, China
4Tangdu Hospital, Fourth Military Medical University, Xi'an, 710038, China
5MOE Key Laboratory for Nonequilibrium Synthesis and Modulation of Condensed Matter, Xi’an Jiaotong University, Xi’an 710049, China
6Sino Biological Inc., Beijing, 100176, China
7Department of Clinical Immunology, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China
8School of Basic Medicine, Fourth Military Medical University, Xi’an, 710032, China

Tóm tắt

Abstract

In face of the everlasting battle toward COVID-19 and the rapid evolution of SARS-CoV-2, no specific and effective drugs for treating this disease have been reported until today. Angiotensin-converting enzyme 2 (ACE2), a receptor of SARS-CoV-2, mediates the virus infection by binding to spike protein. Although ACE2 is expressed in the lung, kidney, and intestine, its expressing levels are rather low, especially in the lung. Considering the great infectivity of COVID-19, we speculate that SARS-CoV-2 may depend on other routes to facilitate its infection. Here, we first discover an interaction between host cell receptor CD147 and SARS-CoV-2 spike protein. The loss of CD147 or blocking CD147 in Vero E6 and BEAS-2B cell lines by anti-CD147 antibody, Meplazumab, inhibits SARS-CoV-2 amplification. Expression of human CD147 allows virus entry into non-susceptible BHK-21 cells, which can be neutralized by CD147 extracellular fragment. Viral loads are detectable in the lungs of human CD147 (hCD147) mice infected with SARS-CoV-2, but not in those of virus-infected wild type mice. Interestingly, virions are observed in lymphocytes of lung tissue from a COVID-19 patient. Human T cells with a property of ACE2 natural deficiency can be infected with SARS-CoV-2 pseudovirus in a dose-dependent manner, which is specifically inhibited by Meplazumab. Furthermore, CD147 mediates virus entering host cells by endocytosis. Together, our study reveals a novel virus entry route, CD147-spike protein, which provides an important target for developing specific and effective drug against COVID-19.

Từ khóa


Tài liệu tham khảo

Jiang, S., Xia, S., Ying, T. & Lu, L. A novel coronavirus (2019-nCoV) causing pneumonia-associated respiratory syndrome. Cell. Mol. Immunol. 5, 554 (2020).

Liu, K. et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin. Med. J. 9, 1025–1031 (2020).

Xu, Z. et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet. Respir. Med. 4, 420–422 (2020).

Zhang, L. et al. The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity. Preprint at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310631/ (2020).

Hulswit, R. J., de Haan, C. A. & Bosch, B. J. Coronavirus spike protein and tropism changes. Adv. Virus Res. 96, 29–57 (2016).

Lan, J. et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature 7807, 215–220 (2020).

Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 2, 271–280 (2020).

Qi, F., Qian, S., Zhang, S. & Zhang, Z. Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses. Biochem. Biophys. Res. Commun. 1, 135–140 (2020).

Daly, J. L. et al. Neuropilin-1 is a host factor for SARS-CoV-2 infection. Science 6518, 861–865 (2020).

Cantuti-Castelvetri, L. et al. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science 6518, 856–860 (2020).

Li, Y. et al. HAb18G (CD147), a cancer-associated biomarker and its role in cancer detection. Histopathology 6, 677–687 (2009).

Lu, M. et al. Basolateral CD147 induces hepatocyte polarity loss by E-cadherin ubiquitination and degradation in hepatocellular carcinoma progress. Hepatology 1, 317–332 (2018).

Pushkarsky, T. et al. CD147 facilitates HIV-1 infection by interacting with virus-associated cyclophilin A. Proc. Natl Acad. Sci. USA 11, 6360–6365 (2001).

Zhang, M. Y. et al. Disrupting CD147-RAP2 interaction abrogates erythrocyte invasion by Plasmodium falciparum. Blood 10, 1111–1121 (2018).

Zhao, P. et al. HAb18G/CD147 promotes cell motility by regulating annexin II-activated RhoA and Rac1 signaling pathways in hepatocellular carcinoma cells. Hepatology 6, 2012–2024 (2011).

Bernard, S. C. et al. Pathogenic Neisseria meningitidis utilizes CD147 for vascular colonization. Nat. Med. 7, 725–731 (2014).

Chen, Z. et al. Function of HAb18G/CD147 in invasion of host cells by severe acute respiratory syndrome coronavirus. J. Infect. Dis. 5, 755–760 (2005).

Gu, J. et al. Multiple organ infection and the pathogenesis of SARS. J. Exp. Med. 3, 415–424 (2005).

Tay, M. Z., Poh, C. M., Renia, L., MacAry, P. A. & Ng, L. The trinity of COVID-19: immunity, inflammation and intervention. Nat. Rev. Immunol. 6, 363–374 (2020).

Yao, H. et al. Important functional roles of basigin in thymocyte development and T cell activation. Int. J. Biol. Sci. 1, 43–52 (2013).

Urra, J. M., Cabrera, C. M., Porras, L. & Rodenas, I. Selective CD8 cell reduction by SARS-CoV-2 is associated with a worse prognosis and systemic inflammation in COVID-19 patients. Clin. Immunol. 217, 108486 (2020).

Harrison, S. C. Viral membrane fusion. Virology 479–480, 498–507 (2015).

Slonska, A., Cymerys, J. & Banbura, M. W. Mechanisms of endocytosis utilized by viruses during infection. Postepy Hig. Med. Dosw. (Online) 572–580 (2016).

Eyster, C. A. et al. Discovery of new cargo proteins that enter cells through clathrin-independent endocytosis. Traffic 5, 590–599 (2009).

Maldonado-Baez, L., Cole, N. B., Kramer, H. & Donaldson, J. G. Microtubule-dependent endosomal sorting of clathrin-independent cargo by Hook1. J. Cell. Biol. 2, 233–247 (2013).

Saitoh, S. et al. Rab5-regulated endocytosis plays a crucial role in apical extrusion of transformed cells. Proc. Natl Acad. Sci. USA 12, E2327–E2336 (2017).

Zhai, P. et al. The epidemiology, diagnosis and treatment of COVID-19. Int. J. Antimicrob. Agents 5, 105955 (2020).

Li, W. et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 6965, 450–454 (2003).

Tipnis, S. R. et al. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J. Biol. Chem. 43, 33238–33243 (2000).

Wong, D. W. et al. Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury. Am. J. Pathol. 2, 438–451 (2007).

Rentzsch, B. et al. Transgenic angiotensin-converting enzyme 2 overexpression in vessels of SHRSP rats reduces blood pressure and improves endothelial function. Hypertension 5, 967–973 (2008).

Der Sarkissian, S. et al. Cardiac overexpression of angiotensin converting enzyme 2 protects the heart from ischemia-induced pathophysiology. Hypertension 3, 712–718 (2008).

Kuba, K., Imai, Y., Ohto-Nakanishi, T. & Penninger, J. M. Trilogy of ACE2: a peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters. Pharm. Ther. 1, 119–128 (2010).

Verdecchia, P., Cavallini, C., Spanevello, A. & Angeli, F. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. Eur. J. Intern. Med. 76, 14–20 (2020).

Tan, L. et al. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Signal Transduct. Target Ther. 1, 33 (2020).

Barth, K., Blasche, R. & Kasper, M. Lack of evidence for caveolin-1 and CD147 interaction before and after bleomycin-induced lung injury. Histochem. Cell. Biol. 5, 563–573 (2006).

Kuba, K. et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat. Med. 8, 875–879 (2005).

Wang, K. et al. Identification of differentially expressed genes in non-small cell lung cancer. Aging 23, 11170–11185 (2019).

Nie, J. et al. Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2. Emerg. Microbes Infect. 1, 680–686 (2020).

Zhang, L. et al. Morphology and structure of lipoproteins revealed by an optimized negative-staining protocol of electron microscopy. J. Lipid Res. 1, 175–184 (2011).

Grigorieff, N. FREALIGN: high-resolution refinement of single particle structures. J. Struct. Biol. 1, 117–125 (2007).

Frank, J. et al. SPIDER and WEB: processing and visualization of images in 3D electron microscopy and related fields. J. Struct. Biol. 1, 190–199 (1996).

Tang, G. et al. EMAN2: an extensible image processing suite for electron microscopy. J. Struct. Biol. 1, 38–46 (2007).

Ludtke, S. J., Baldwin, P. R. & Chiu, W. EMAN: semiautomated software for high-resolution single-particle reconstructions. J. Struct. Biol. 1, 82–97 (1999).

Ohi, M., Li, Y., Cheng, Y. & Walz, T. Negative staining and image classification - powerful tools in modern electron microscopy. Biol. Proced. Online 23–34 (2004).

Almabouada, F. et al. Adiponectin receptors form homomers and heteromers exhibiting distinct ligand binding and intracellular signaling properties. J. Biol. Chem. 5, 3112–3125 (2013).